These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 26715439)
1. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression. Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439 [TBL] [Abstract][Full Text] [Related]
2. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
5. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma. Xiong Y; Hu B; Wei L; Jiang D; Zhu M Tumour Biol; 2015 Dec; 36(12):9579-88. PubMed ID: 26141041 [TBL] [Abstract][Full Text] [Related]
7. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251 [TBL] [Abstract][Full Text] [Related]
8. High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma. Hu B; Jiang D; Chen Y; Wei L; Zhang S; Zhao F; Ni R; Lu C; Wan C Tumour Biol; 2015 Apr; 36(4):2569-81. PubMed ID: 25874485 [TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients. Bai B; Lin Y; Hu J; Wang H; Li L; Zhao S; Zhang J; Meng W; Yue P; Bai Z; Li X Oncol Rep; 2019 Mar; 41(3):1539-1548. PubMed ID: 30747220 [TBL] [Abstract][Full Text] [Related]
10. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma. Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429 [TBL] [Abstract][Full Text] [Related]
11. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131 [TBL] [Abstract][Full Text] [Related]
12. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Tian F; Cai D Gene; 2022 Jan; 807():145964. PubMed ID: 34530087 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
15. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo. Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817 [TBL] [Abstract][Full Text] [Related]
16. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation. Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420 [TBL] [Abstract][Full Text] [Related]
17. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-143 promotes cell proliferation by regulating PKCε in hepatocellular carcinoma cells. Tang H; Li X; Yang R Mol Med Rep; 2017 Oct; 16(4):4348-4354. PubMed ID: 28765889 [TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
20. High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcome. Li HJ; Sun QM; Liu LZ; Zhang J; Huang J; Wang CH; Ding R; Song K; Tong Z Oncol Rep; 2015 Aug; 34(2):795-802. PubMed ID: 26082242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]